Company page

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. is a publicly traded biotechnology company focused on developing genomic therapies for various diseases. The company utilizes its proprietary technology platform to create innovative treatments aimed at addressing genetic disorders and other serious health conditions. Sangamo is headquartered in the United States and is listed on the American stock market under the ticker symbol SGMO.